FDA Inspection 1178672 — Children's National Medical Center

Children's National Medical Center — FEI 1177084

The FDA completed an inspection of Children's National Medical Center on August 19, 2022 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 19, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Washington, DC (United States)